Cryoablation offers rapid, significant, and durable pain relief for patients with bone tumors, particularly those with metastases unresponsive to conventional treatments. It effectively reduces pain intensity, improves quality of life, and lowers dependence on opioid analgesics.
With real-time imaging guidance such as CT, cryoablation allows precise targeting of tumors and controlled ice ball formation, achieving extensive tumor necrosis while maximizing protection of surrounding healthy bone and soft tissue. Enhances local tumor control rates with a low incidence of major complications.
Cryoablation not only directly destroys tumor cells but also activates immune effector cells, inducing a systemic anti-tumor immune response and providing strong support for combination immunotherapy
References
Callstrom MR et al. Cryoablation for Palliation of Painful Bone Metastases: The MOTION Multicenter Study. Radiology, 2021. DOI: 10.1148/radiol.2021203831
Arrigoni F et al. Role of Percutaneous Cryoablation in Bone and Soft Tissue Tumors. Frontiers in Oncology, 2023. DOI: 10.3389/
Yashiro T et al. Cryoablation for Malignant Bone and Soft Tissue Tumors: Local Control Rates and Safety. Anticancer Research, 2024. DOI: 10.21873